Companies / Japan
Despite Reforms, Doubts Over Japanese Generics Remain
April 2006 | Company Finance AlertJapan's recent reforms to market rules for generic medicines could have a limited short-term impact, despite a warm welcome from international players such as Sandoz and Ranbaxy. A new format for doctor scripts, set to roll out this month, allows prescribers to indicate whether a branded drug can be substituted for a generic. However, the outlook for Japan's generics market remains threatened by negative consumer perceptions, and archaic rules enabling doctors to profit from dispensing pharmaceuticals. A separated dispensing and prescribing system - known as bungyo - is still not compulsory in
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
